GSA Capital Partners’s Cantel Medical Corporation CMD Stock Holding History

GSA Capital Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,142	Closed	-$563K	–	1651
2020 Q4	$563K	Sell	7,142 -7,575	-51%	-$444K	0.09%	356
2020 Q3	$647K	Buy	+14,717	New	+$725K	0.11%	259
2020 Q2	–	Sell	-5,749	Closed	-$206K	–	1305
2020 Q1	$206K	Buy	+5,749	New	+$327K	0.05%	741
2018 Q4	–	Sell	-12,104	Closed	-$1.11M	–	1899
2018 Q3	$1.11M	Sell	12,104 -1,902	-14%	-$181K	0.06%	616
2018 Q2	$1.38M	Buy	+14,006	New	+$1.57M	0.07%	516
2017 Q2	–	Sell	-7,675	Closed	-$615K	–	2055
2017 Q1	$615K	Buy	+7,675	New	+$610K	0.03%	971
2016 Q3	–	Sell	-8,277	Closed	-$569K	–	2057
2016 Q2	$569K	Buy	+8,277	New	+$571K	0.03%	985
2016 Q1	–	Sell	-14,240	Closed	-$885K	–	2007
2015 Q4	$885K	Buy	+14,240	New	+$869K	0.04%	790
2015 Q3	–	Sell	-4,775	Closed	-$256K	–	2119
2015 Q2	$256K	Sell	4,775 -1,400	-23%	-$68.1K	0.01%	1696
2015 Q1	$293K	Buy	+6,175	New	+$273K	0.01%	1722

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GSA Capital Partners's CMD Position: Q1 2021 in Review

GSA Capital Partners sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 7,142 shares — an estimated $563K sold.

GSA Capital Partners first reported a position in CMD in Q1 2015 and held it in 10 quarters. The position peaked at $1.38M in Q2 2018. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

GSA Capital Partners reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
GSA Capital Partners sold 7,142 Cantel Medical Corporation shares in Q1 2021, an estimated $563K.
GSA Capital Partners first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 10 quarters.
GSA Capital Partners's Cantel Medical Corporation position peaked at $1.38M in Q2 2018.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.